Panelist

Dr. Catriona Jamieson is a leading physician-scientist who discovered missplicing, RNA hyper-editing, and splice isoform switching as mechanisms governing human cancer stem cell maintenance in selective niches. Dr. Jamieson has extensive experience in development of stem cell models and therapies, including small molecule drugs, as well as commercialization of these technologies. At the Sanford Stem Cell Institute, Dr. Jamieson and her team are examining the links between aging and systemic inflammation-related microenvironmental and macroenvironmental stressors that promote pre-cancer initiation and malignant transformation of human hematopoietic stem and progenitor cells. As part of the NASA Integrated Space Stem Cell Orbital Research (ISSCOR) program, Dr. Jamieson has led the engineering of human hematopoietic stem cell and tumor organoid nanobioreactors and development of multi-omic and functional analytical methods to determine stem cell fitness before, during and after space flight. Dr. Jamieson received the 2017 MPN Hero’s Award, the Moores Cancer Center Rell Sunn Award in 2020, and the Top Doctor for the 10th consecutive year by Castle Connolly in 2021. She has served as a keynote speaker on stem cells and pre-cancer and was awarded the UC San Diego Academic Senate Distinguished Research Award in 2023 and will be awarded the Luminary Award, Precision Medicine World Conference, in 2024.